EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ABCA4 c.6480-35A>G, a novel branchpoint variant associated with Stargardt disease

María Rodríguez-Hidalgo, Suzanne E de Bruijn, Zelia Corradi, Kim Rodenburg, Araceli Lara-López, Alicia Valverde-Megías, Almudena Ávila-Fernández, Lidia Fernandez-Caballero, Marta Del Pozo-Valero, Jordi Corominas, Christian Gilissen, Cristina Irigoyen und 4 weitere

Frontiers in Genetics · 07.09.2023 · 14

DOI: 10.3389/fgene.2023.1234032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Genetics, online erschienen am 07.09.2023. Verfasst von María Rodríguez-Hidalgo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Biodonostia Health Research Institute, Donostia-San Sebastián, Spain. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Inherited retinal dystrophies (IRDs) can be caused by variants in more than 280 genes. The ATP-binding cassette transporter type A4 ( ABCA4 ) gene is one of these genes and has been linked to Stargardt disease type 1 (STGD1), fundus flavimaculatus, cone–rod dystrophy (CRD), and pan-retinal CRD. Approximately 25% of the reported ABCA4 variants affect RNA splicing. In most cases, it is necessary to perform a functional assay to determine the effect of these variants.

Methods

Whole genome sequencing (WGS) was performed in one Spanish proband with Stargardt disease. The putative pathogenicity of c.6480-35A>G on splicing was investigated both in silico and in vitro . The in silico approach was based on the deep-learning tool SpliceAI. For the in vitro approach we used a midigene splice assay in HEK293T cells, based on a previously established wild-type midigene (BA29) containing ABCA4 exons 46 to 48.

Results

Through the analysis of WGS data, we identified two candidate variants in ABCA4 in one proband: a previously described deletion, c.699_768+342del (p.(Gln234Phefs*5)), and a novel branchpoint variant, c.6480-35A>G. Segregation analysis confirmed that the variants were in trans . For the branchpoint variant, SpliceAI predicted an acceptor gain with a high score (0.47) at position c.6480-47. A midigene splice assay in HEK293T cells revealed the inclusion of the last 47 nucleotides of intron 47 creating a premature stop codon and allowed to categorize the variant as moderately severe. Subsequent analysis revealed the presence of this variant as a second allele besides c.1958G>A p.(Arg653His) in an additional Spanish proband in a large cohort of IRD cases.

Conclusion

A splice-altering effect of the branchpoint variant, confirmed by the midigene splice assay, along with the identification of this variant in a second unrelated individual affected with STGD, provides sufficient evidence to classify the variant as likely pathogenic. In addition, this research highlights the importance of studying non-coding regions and performing functional assays to provide a conclusive molecular diagnosis.

Schlagwörter

Stichwörter der Autor:innen

ABCA4Stargardt diseasebranchpoint variantmidigene splice assaywhole genome sequencing

Autor:innen und Institutionen

  • Department of Neuroscience, Biodonostia Health Research Institute, Donostia-San Sebastián, Spain.
  • Department of Genetic, Physical Anthropology and Animal Physiology, University of the Basque Country UPV/EHU, Leioa, Spain.
  • Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
  • Miramoon Pharma S.L., Donostia-San Sebastián, Spain.
  • Ophthalmology Service, San Carlos Clinical Hospital of Madrid, Madrid, Spain.
  • Department of Genetics, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.

Zitieren

APA

Rodríguez-Hidalgo, M., de Bruijn, S. E., Corradi, Z., Rodenburg, K., Lara-López, A., Valverde-Megías, A., Ávila-Fernández, A., Fernandez-Caballero, L., Del Pozo-Valero, M., Corominas, J., Gilissen, C., Irigoyen, C., Cremers, F. P. M., Ayuso, C., Ruiz-Ederra, J., & Roosing, S. (2023). ABCA4 c.6480-35A>G, a novel branchpoint variant associated with Stargardt disease. Frontiers in Genetics, 14. https://doi.org/10.3389/fgene.2023.1234032

Vancouver

Rodríguez-Hidalgo M, de Bruijn SE, Corradi Z, Rodenburg K, Lara-López A, Valverde-Megías A, et al. ABCA4 c.6480-35A>G, a novel branchpoint variant associated with Stargardt disease. Frontiers in Genetics. 2023;14. doi:10.3389/fgene.2023.1234032

BibTeX
@article{RodrguezHidalgo2023,
  author = {Rodríguez-Hidalgo, María and de Bruijn, Suzanne E and Corradi, Zelia and Rodenburg, Kim and Lara-López, Araceli and Valverde-Megías, Alicia and Ávila-Fernández, Almudena and Fernandez-Caballero, Lidia and Del Pozo-Valero, Marta and Corominas, Jordi and Gilissen, Christian and Irigoyen, Cristina and Cremers, Frans P M and Ayuso, Carmen and Ruiz-Ederra, Javier and Roosing, Susanne},
  title = {ABCA4 c.6480-35A>G, a novel branchpoint variant associated with Stargardt disease},
  journal = {Frontiers in Genetics},
  year = {2023},
  volume = {14},
  doi = {10.3389/fgene.2023.1234032}
}
Kostenlos starten →